ALHC Alignment Healthcare, Inc.

QT25

NASDAQ·Healthcare·Medical - Healthcare Plans·USA

Latest market price

7.00

-0.27-3.71%

Overview Short InterestFilings

ALHCQT25Alignment Healthcare, Inc.·NASDAQ

Overview Short InterestFilings

7.00-3.71%

News

Down 3.7% — Alignment Healthcare (ALHC) Stock Looks Reasonably Valued Following The CMS Ratings Cut (Yahoo).

Medium confidence

Loading chart...

Signal & projected range

QT Score downgradeHistorical pattern — not a prediction

Range still being built for this setupWe don’t yet have a frozen historical track record for qt score downgrade to describe a reliable spread of outcomes. The projected range appears once its backtest is established.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

PGNY+0.75%$29.41 CLOV-3.36%$4.31 OSCR+2.07%$31.00 MOH+1.79%$208.45 CNC-2.81%$66.53 HUM-0.99%$410.41 CI-1.02%$295.19 ELV-1.54%$413.60

Snapshot

Index	—	P/E	53.85	EPS (ttm)	0.13	Insider Own	—	Shs Outstand	207.44M	Perf Week	-11.28%

Market Cap	1.45B	Forward P/E	41.72	EPS next Y	0.17	Insider Trans	-0.76%	Shs Float	188.21M	Perf Month	-11.84%

Enterprise Value	1.04B	PEG	—	EPS next Q	—			Short Float	13.56%	Perf Quarter	-48.22%

Income	29.00M	P/S	0.29	EPS this Y	—			Short Ratio	3.07	Perf Half Y	-63.66%

Sales	4.94B	P/B	5.24	EPS next Y	—	ROA	2.23%	Short Interest	25.52M	Perf YTD	-64.56%

Book/sh	1.34	P/C	1.95	EPS next 5Y	—	ROE	12.46%	52W High	25.12 -72.13%	Perf Year	-59.11%

Cash/sh	3.58	P/FCF	17.49	EPS past 3/5Y	—	ROIC	7.16%	52W Low	6.01 16.47%	Perf 3Y	-1.55%

Dividend Est.	—	EV/EBITDA	13.85	Sales past 3/5Y	40.17% 32.72%	Gross Margin	11.93%	Volatility	6.41% 6.20%	Perf 5Y	-64.84%

Dividend TTM	—	EV/Sales	0.21	EPS Y/Y TTM	—	Oper. Margin	0.88%	ATR (14)	0.55	Perf 10Y	—

Dividend Ex-Date	—	Quick Ratio	1.71	Sales Y/Y TTM	35.88%	Profit Margin	0.59%	RSI (14)	29.45	Recom	2.25

Dividend Gr. 3/5Y	—	Current Ratio	1.71	EPS Q/Q	—	SMA20	-13.86%	Beta	1.04	Target Price	12.29

Payout	0.00%	Debt/Eq	1.19	Sales Q/Q	36.62%	SMA50	-28.20%	Rel Volume	0.83	Prev Close	7.27

Employees	1,849	LT Debt/Eq	1.19	Earnings	Feb 25	SMA200	-58.16%	Avg Volume	8.26M	Price	7.00

IPO Date	Mar 26, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.96% —	Net Debt/EBITDA	-5.51	Volume	6,858,629	Change	-3.71%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Oct-30-26	Reiterated	Piper Sandler	Overweight	$30 → $15
Oct-30-26	Downgrade	Keybanc	Overweight → Sector Weight
Oct-22-26	Reiterated	Goldman Sachs	Buy	$25 → $12
Oct-12-26	Reiterated	UBS	Neutral	$22 → $9.00
Oct-09-26	Reiterated	Scotiabank		$9.00
Oct-09-26	Reiterated	Keybanc	Overweight	$28 → $12
Oct-09-26	Downgrade	William Blair	Outperform → Market Perform
Oct-06-26	Reiterated	Barclays	Equal Weight	$16 → $10
Aug-03-26	Downgrade	Raymond James	Strong Buy → Outperform	$22 → $19
May-26-26	Reiterated	Barclays	Equal Weight	$19 → $16

Latest News· Times ET

Nov-02-26

Nov-02-2605:38AM

ALHC Legal Notice: Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigationbusinesswire.com

Nov-01-26

Nov-01-2612:16AM

Alignment Healthcare (ALHC) Stock Looks Reasonably Valued Following The CMS Ratings CutYahoo

Oct-30-26

Oct-30-2610:00PM

Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHCprnewswire.com

01:41PM

Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSSprnewswire.com

11:00AM

Lost Money on Alignment Healthcare, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Continues Investigating Possible Securities Fraud After 16.7% Share Price Dropglobenewswire.com

09:26AM

ALHC INVESTIGATION: Alignment Healthcare Investors Should Contact Block & Leviton to Possibly Recover Lossesnewsfilecorp.com

06:18AM

ALHC Investigation Reminder: Alignment Healthcare Under Investigation for Potential Securities Fraud Over Inflated EBITDA – Contact BFA Law if You Lost Moneyglobenewswire.com

Oct-29-26

Oct-29-2609:38PM

Alignment Healthcare, Inc. (ALHC) Q3 2026 Earnings Call Transcriptseekingalpha.com

08:15PM

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Callmarketbeat.com

08:06PM

Alignment Healthcare (ALHC) Reports Q3 Loss, Beats Revenue Estimateszacks.com

08:01PM

Here's What Key Metrics Tell Us About Alignment Healthcare (ALHC) Q3 Earningszacks.com

04:01PM

Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlookglobenewswire.com

Oct-28-26

Oct-28-2606:50AM

Allspring Emerging Growth Fund: Q3 2026 Top Contributors And Detractorsseekingalpha.com

06:36AM

$ALHC Stock Market Alert: Alignment Healthcare Investigated for Securities Fraud after Inflated EBITDA Leads to 16% Stock Drop – Contact BFA Law if You Lost Moneyglobenewswire.com

Oct-27-26

Oct-27-2605:46AM

ALHC Investor Investigation: Alignment Healthcare Investors Are Alerted to the Securities Fraud Investigation after Inflated EBITDA Leads to 16% Stock Dropprnewswire.com

Company

Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada. Beyond its proprietary offerings, it also orchestrates and furnishes essential healthcare services—including professional, institutional, and supplementary care—for beneficiaries of select plans from unrelated Medicare Advantage Health Maintenance Organizations. Established in 2013, Alignment Healthcare maintains its corporate base in Orange, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019
Total Revenue	4,942	3,949	2,704	1,824	—	—	—	—
Cost of Goods Sold Incl. D&A	4,353	3,460	2,407	1,623	—	—	—	—
Gross Profit	589	489	297	201	—	—	—	—
Selling, General and Administrative Excl. Other	388	0	371	307	—	—	—	—
Research and Development	0	0	0	0	—	—	—	—
Other Operating Expense	158	474	27	22	—	—	—	—
Operating Income	44	15	-102	-128	—	—	—	—
Interest Expense	16	16	24	21	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	0	0	-3	1	—	—	—	—
Net Income Before Taxes	27	-1	-128	-148	—	—	—	—
Income Taxes	-2	0	0	0	—	—	—	—
Consolidated Net Income	29	-1	-128	-148	—	—	—	—
Net Income From Continuing Operations	29	-1	-128	-148	—	—	—	—
Net Income	29	-1	-128	-148	—	—	—	—
EPS (Recurring)	0.14	-0.00	-0.67	-0.79	—	—	—	—
EPS (Basic, Before Extraordinaries)	0.14	-0.00	-0.67	-0.79	—	—	—	—
EPS (Diluted)	0.13	-0.00	-0.67	-0.79	—	—	—	—
EBITDA	75	45	-77	-105	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—
Price To Earnings Ratio	53.85	—	—	—	—	—	—	—
Price To Sales Ratio	0.30	0.99	0.79	0.88	—	—	—	—
Gross Margin	11.92	12.38	10.98	11.02	—	—	—	—
Operating Margin	0.89	0.38	-3.77	-7.02	—	—	—	—
Net Margin	0.59	-0.03	-4.73	-8.11	—	—	—	—
Shares Outstanding	209	198	191	186	—	—	—	—
Market Capitalization	1,463	3,911	2,149	1,601	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kim Hyong	Chief Medical Officer	Oct 06 '26	Sale	8.30	32,479	269,576	299,271	Oct 07
KONOWIECKI JOSEPH S	EVP, Corporate Affairs	Sep 17 '26	Sale	8.61	23,511	202,430	1,080,305	Sep 18
KAO JOHN E	Chief Executive Officer	Sep 14 '26	Sale	13.00	27,400	356,200	590,766	Sep 16
Maroney Dawn Christine	President	Sep 11 '26	Sale	12.68	122,707	1,555,925	794,606	Sep 11
KAO JOHN E	Chief Executive Officer	Sep 11 '26	Sale	12.68	385,270	4,885,224	1,223,473	Sep 11
KAO JOHN E	Chief Executive Officer	Sep 10 '26	Sale	12.96	172,600	2,236,447	618,166	Sep 11
Maroney Dawn Christine	President	Aug 14 '26	Sale	14.00	5,000	70,000	917,313	Aug 18
KAO JOHN E	Chief Executive Officer	Aug 10 '26	Sale	13.88	298,000	4,136,776	790,766	Aug 10
Maroney Dawn Christine	President	Jul 15 '26	Option Exercise	9.06	152,068	1,377,736	1,099,381	Jul 16
Maroney Dawn Christine	President	Jul 15 '26	Sale	20.83	177,068	3,687,990	922,313	Jul 16
KAO JOHN E	Chief Executive Officer	Jul 10 '26	Sale	19.86	298,000	5,919,361	1,088,766	Jul 14
KONOWIECKI JOSEPH S	EVP, Corporate Affairs	Jul 01 '26	Sale	24.00	25,000	600,000	1,103,816	Jul 01
KONOWIECKI JOSEPH S	EVP, Corporate Affairs	Jun 26 '26	Sale	23.00	25,000	575,000	1,128,816	Jun 26
KONOWIECKI JOSEPH S	EVP, Corporate Affairs	Jun 18 '26	Sale	22.00	25,000	550,000	1,153,816	Jun 18
Maroney Dawn Christine	President	Jun 15 '26	Sale	19.55	30,000	586,425	947,313	Jun 15

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.